Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Other financing activities (2022 - 2024)

Tandem Diabetes Care filings provide 4 years of Other financing activities readings, the most recent being $183000.0 for Q1 2024.

  • On a quarterly basis, Other financing activities changed N/A to $183000.0 in Q1 2024 year-over-year; TTM through Dec 2024 was $183000.0, a 357.75% increase, with the full-year FY2024 number at $183000.0, up 357.75% from a year prior.
  • Other financing activities hit $183000.0 in Q1 2024 for Tandem Diabetes Care, up from -$71000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $183000.0 in Q1 2024 to a low of -$405000.0 in Q3 2022.
  • Median Other financing activities over the past 3 years was $6000.0 (2022), compared with a mean of -$52500.0.
  • The widest YoY moves for Other financing activities: up 82.47% in 2023, down 82.47% in 2023.
  • Tandem Diabetes Care's Other financing activities stood at $83000.0 in 2022, then crashed by 185.54% to -$71000.0 in 2023, then skyrocketed by 357.75% to $183000.0 in 2024.
  • The last three reported values for Other financing activities were $183000.0 (Q1 2024), -$71000.0 (Q3 2023), and $83000.0 (Q4 2022) per Business Quant data.